Advertisement
Person › Details
Carl L. Gordon (OrbiMed (Group))
Gordon, Carl L. (OrbiMed Advisors 201509 Partner)
Organisation | OrbiMed (Group) | |
Product | venture capital | |
Product 2 | LIFE SCIENCES | |
Record changed: 2023-10-25 |
Advertisement
More documents for Carl L. Gordon
- [1] Alterome Therapeutics, Inc.. (1/19/22). "Press Release: Alterome Therapeutics Launches with $64M Series A Financing". San Diego, CA....
- [2] Odyssey Therapeutics, Inc.. (12/7/21). "Press Release: Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines". Boston, MA....
- [3] Kinnate Biopharma, Inc.. (12/19/19). "Press Release: Kinnate Biopharma Closes $74.5M Series B Financing". San Diego, CA....
- [4] Arsanis, Inc.. (4/26/17). "Press Release: Arsanis Completes $45.5 Million Series D Financing". Waltham, MA & Vienna....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top